Jacqueline Cloos
Jacqueline Cloos
Research coordinator Pediatric Oncology/Hematology and Hematology, VU University Medical Center, Amsterdam
Email yang diverifikasi di vumc.nl
JudulDikutip olehTahun
Cell sensitivity assays: the MTT assay
J Van Meerloo, GJL Kaspers, J Cloos
Cancer cell culture, 237-245, 2011
9962011
Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features
M Kool, J Koster, J Bunt, NE Hasselt, A Lakeman, P Van Sluis, D Troost, ...
PloS one 3 (8), e3088, 2008
6462008
Molecular basis of bortezomib resistance: proteasome subunit β5 (PSMB5) gene mutation and overexpression of PSMB5 protein
R Oerlemans, NE Franke, YG Assaraf, J Cloos, I van Zantwijk, CR Berkers, ...
Blood 112 (6), 2489-2499, 2008
3962008
Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia
K De Keersmaecker, ZK Atak, N Li, C Vicente, S Patchett, T Girardi, ...
Nature genetics 45 (2), 186, 2013
3072013
European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on …
D Averbuch, C Orasch, C Cordonnier, DM Livermore, M Mikulska, ...
haematologica 98 (12), 1826-1835, 2013
2592013
Molecular signature associated with bone marrow micrometastasis in human breast cancer
U Woelfle, J Cloos, G Sauter, L Riethdorf, F Jänicke, P Van Diest, ...
Cancer research 63 (18), 5679-5684, 2003
2512003
miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis
M Smits, J Nilsson, SE Mir, PM van der Stoop, E Hulleman, JM Niers, ...
Oncotarget 1 (8), 710, 2010
2342010
Genetic susceptibility to head and neck squamous cell carcinoma
J Cloos, MR Spitz, SP Schantz, TC Hsu, Z Zhang, H Tobi, BJM Braakhuis, ...
JNCI: Journal of the National Cancer Institute 88 (8), 530-535, 1996
2091996
In silico analysis of kinase expression identifies WEE1 as a gatekeeper against mitotic catastrophe in glioblastoma
SE Mir, PCDW Hamer, PM Krawczyk, L Balaj, A Claes, JM Niers, ...
Cancer cell 18 (3), 244-257, 2010
2042010
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
GJ Schuurhuis, M Heuser, S Freeman, MC Béné, F Buccisano, J Cloos, ...
Blood 131 (12), 1275-1291, 2018
1992018
Molecular minimal residual disease in acute myeloid leukemia
M Jongen-Lavrencic, T Grob, D Hanekamp, FG Kavelaars, A Al Hinai, ...
New England Journal of Medicine 378 (13), 1189-1199, 2018
1832018
Stability and prognostic influence of FLT3 mutations in paired initial and relapsed AML samples
J Cloos, BF Goemans, CJ Hess, JW Van Oostveen, Q Waisfisz, S Corthals, ...
Leukemia 20 (7), 1217, 2006
1602006
Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML
IHIM Hollink, CM Zwaan, M Zimmermann, T Arentsen-Peters, R Pieters, ...
Leukemia 23 (2), 262, 2009
1522009
The human equilibrative nucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemia
I Hubeek, RW Stam, GJ Peters, R Broekhuizen, JPP Meijerink, ...
British journal of cancer 93 (12), 1388, 2005
1502005
Inherited susceptibility to bleomycin-induced chromatid breaks in cultured peripheral blood lymphocytes
J Cloos, EJC Nieuwenhuis, DI Boomsma, DJ Kuik, MLT Van Der Sterre, ...
Journal of the National Cancer Institute 91 (13), 1125-1130, 1999
1361999
Impaired bortezomib binding to mutant β5 subunit of the proteasome is the underlying basis for bortezomib resistance in leukemia cells
NE Franke, D Niewerth, YG Assaraf, J van Meerloo, K Vojtekova, ...
Leukemia 26 (4), 757, 2012
1342012
Comprehensive analysis of transcriptome variation uncovers known and novel driver events in T-cell acute lymphoblastic leukemia
ZK Atak, V Gianfelici, G Hulselmans, K De Keersmaecker, AG Devasia, ...
PLoS genetics 9 (12), e1003997, 2013
1112013
Increased mutagen sensitivity in head‐and‐neck squamous‐cell carcinoma patients, particularly those with multiple primary tumors
J Cloos, BJM Braakhuis, I Steen, MP Copper, N De Vries, JJP Nauta, ...
International journal of cancer 56 (6), 816-819, 1994
1111994
Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia
BV Balgobind, IHIM Hollink, ST Arentsen-Peters, M Zimmermann, ...
haematologica 96 (10), 1478-1487, 2011
992011
Down-regulation of miR-101 in endothelial cells promotes blood vessel formation through reduced repression of EZH2
M Smits, SE Mir, RJA Nilsson, PM van der Stoop, JM Niers, VE Marquez, ...
PloS one 6 (1), e16282, 2011
942011
Sistem tidak dapat melakukan operasi ini. Coba lagi nanti.
Artikel 1–20